Skip to main content
. Author manuscript; available in PMC: 2019 Nov 11.
Published in final edited form as: Anticancer Res. 2018 Nov;38(11):6361–6366. doi: 10.21873/anticanres.12994

Table II.

Sensitivity of immunohistochemical staining intensity of podocalyxin, TRA-1–60 and TRA-1–81 in prostate cancer.

Biomarker High-grade tumors Low-grade tumors PIN
Podocalyxin 54/55=0.98 (0.92–1.00) 71/81=0.88 (0.80–0.92) 62/77=0.81 (0.72–0.87)
TRA-1-60 8/55=0.15 (0.08–0.24) 17/80=0.21 (0.15–0.30) 8/74=0.11 (0.06–0.18)
TRA-1-81 7/54=0.13 (0.07–0.22) 12/78=0.15 (0.10–0.23) 6/75=0.08 (0.04–0.15)

Only prostate tumor tissue slides were used to assess the sensitivity of the staining intensity for each protein. Point estimates of the sensitivity of the staining intensity with the 90% Wilson type confidence limits for each protein are shown in parentheses. PIN: Prostatic intraepithelial neoplasia.